award points to ATLA's 'lifetime achievements' in helping to create, nurture and sustain an international community of people interested in alternatives. Its impact was felt in the USA at a time when we were still finding our way. Rita and Susan's recent Editorial 1 about ATLA's truly international standing refers to this, and we agree with them. " It was proposed that the award should be accepted on ATLA's behalf by Martin Stephens of the Humane Society of the United States, a member of the journal's Editorial Board, on 18 October, during an In Vitro Alternatives Forum, organised by the Institute for In Vitro Sciences (IIVS), which was to be held in Alexandria, VA, USA. However, I decided to go to Alexandria to accept the award myself, partly because IIVS meetings are always outstanding (and this one was no exception), and partly because it is rather unusual for an American institution to recognise the value of something done by non-Americans outside the USA (the 'NIH [Not Invented Here] syndrome' is well known in scientific research and publishing). However, my main reason was that the ARDF award was very special, as it recognised the value of the memorable contributions of a series of teams over nearly 40 years, since Abstracts of Alternatives to Laboratory Animals first appeared in June 1973. In Table 1 , I have listed the Editors and Associate Editors, Assistant Editors and Production Editors, and Editorial Assistants who deserve credit, but others must also be mentioned, namely, the abstractors, advisers, editorial board members, reviewers, secretaries, sponsors, and, especially, authors, whose contributions have been so vital to the journal's survival, let alone its success. I must also give specific recognition to Tony Marson, of 4 Sheets Design and Print Limited, partner since 1982, who has been responsible for the typesetting and printing of the journal (and most of FRAME's other publications) -and especially for encouraging us to try to keep up with the latest technology.
Developments in the production of ATLA
The early days of ATLA Abstracts have recently been described with honesty and affection by Andrew Rowan, 2 who was its Editor from 1976 to 1978. The aim of the founders of FRAME was to inform scientists about alternative methods described in the literature. However, the abstracts published were not those of the authors of the original papers -they were written by professional abstractors, with an emphasis on the replacement, and, to a lesser extent, on the reduction, of laboratory animal experiments. This was no mean achievement -for example, ATLA Abstracts 5(1), June 1977, contained 256 abstracts, classified into 16 sections ( Table 2) .
Although an immense amount of thought and effort was put into ATLA Abstracts, and although those who used it found it very helpful, the journal never achieved a satisfactory number of subscriptions. From Volume 4 (1976), review articles and news items began to be included, and a collection of selected reviews was subsequently published. 3 Unfortunately, this widening of the scope of the journal did not lead to a sufficient increase in circulation, so, in 1980, the FRAME Trustees decided that the journal should be renamed ATLA (Alternatives to Laboratory Animals) and should be transformed, in two stages, into a more conventional journal.
Looking back from the perceived sophistication of today's instant-information-dominated world, this might all seem rather naïve. That would be wrong -FRAME's initiative was, in fact, highly original and very courageous, and, like many other initiatives taken over the Charity's first 40 years, ahead of its time. However, the work was very labour-intensive, since in 1973 there were no fax machines, no word processors, no office computers or personal computers, no helpful computer programs such as Word Perfect or Word, no e-mails, no World Wide Web, and no Internet. All that the pioneers involved could expect was access to an electric typewriter and a photocopier. As the focus on news & views, comments and review articles, original research papers, and book reviews increased, all contacts were by mail: manuscripts were received, referees' comments requested and received, revised manuscripts requested and received, and proofs sent and returned -all by post, which took weeks, if not months.
Abstracts continued to be published in ATLA until volume 9(1), June 1981, after which they were replaced by Selected Titles. The titles to be included were selected from literature surveys regularly conducted for FRAME by Pfizer Central Research, Sandwich, Kent, UK, through the good offices of Dr David Bawden, Dr Ian Sinclair, and others. Selected Titles continued to appear until volume 34(3), June 2006, principally at Vivienne Hunter's insistence, and was made possible by her skill and patience in making the selections.
From Volume 9 (1981), ATLA was reduced in size from the former A4 format, but was still reproduced from camera-ready copy provided by the FRAME office, having been typed on a machine which had the advantage of proportional spacing, but the disadvantage that some of the letters were out of line, including 'o', which, of course, appeared much more frequently than other letters, such as 'q' or 'z', which would have caused less concern. One of my first moves when I took over as Acting Director of FRAME in January 1982, just after the move from Wimbledon to Nottingham, was to purchase a new machine.
More changes were to follow very rapidly, since, by June 1982, it was announced that, from volume 11 (1983), ATLA would be published four times a year, rather than only twice, with an international editorial board, and would be typeset and bound, rather than stapled. Meanwhile, we had obtained our first word processor, a Commodore, which may have been used to produce ATLA 10 (1 and 2, June and December 1982), and was certainly used to produce the camera-ready copy of Animals and Alternatives in Toxicity Testing in 1983, 4 the report of a conference held at the Royal Society in 1982, to discuss the first report of the FRAME Toxicity Committee. In 1990, a further, major restyling took place, beginning with a two-column pagination, singleissue volume 18, produced to celebrate FRAME's 21st Anniversary. This volume contained many valuable reviews, plus two significant workshop reports -one on the CAAT/ERGATT workshop on the principles of validation (now known as Amden 1), and one on the ERGATT/FRAME/ European Commission workshop on promotion of the regulatory acceptance of validated, non-animal, toxicity test procedures. These reports were to establish the style of the subsequent, very successful, ECVAM workshop series, which began in 1994, the year in which ATLA increased its publication frequency from four to six issues per volume.
When I moved to ECVAM in 1993, my continued role as Editor was made possible by the fax machine installed in our villa. During my nine years in Italy, I exchanged thousands of faxes with Vivienne Hunter at FRAME, which I acted upon early in the morning, at lunchtime and in the evening on weekdays, and during weekends (but never during European Commission time or using European Commission equipment), often sitting overlooking Lago di Monate, with a glass of Pinot Grigio or Montepulciano d'Abruzzo nearby.
My return to the UK in 2002 coincided with the last major changes to the ATLA format. The 1990 restyling still gave the journal a relatively modern look, but the return of the page size to A4 from volume 30 (2002) permitted an increase in font size to make the text more readable. The larger page was also more suitable for the complex tables which characterise in vitro toxicology and, in particular, reports on prevalidation and validation studies. In addition, the front cover was made more interesting, providing a hint of the issue's main highlights, and it progressively became possible to include illustrations in colour at an acceptable cost.
At about this time, there were major changes in the editing process, taking full benefit of the advances offered by personal computers, some superb computer programs and e-mailing. It is now possible to receive manuscripts, have them refereed, have questions answered and new versions produced, do the editing, have the typeset version produced, send the proofs to authors, and receive and make corrections -all without leaving the office (or, in my case, the spare bedroom). I now rarely post an envelope, and I didn't replace my fourth fax machine, when it finally gave up the ghost. I can communicate with Susan Trigwell at FRAME on a minute-to-minute basis. We can receive a manuscript from an author and fully process it within a week, and I can write an editorial in the morning, and have it reviewed, edited, typeset and ready for publication before the end of the day. The main disadvantage is that one is tied to the machine, so sitting in the garden with a glass of wine is not possible -but even that is changing, as the challenge of yet more new technology has to be faced.
The character of ATLA
From volume 11 (1983), we set out to make ATLA a kind of Trends in Alternatives journal, combining news and opinion with peer-reviewed research reports. Since this was seen as an essential way of spreading FRAME's message, there were no limits on pages per volume and no budget restrictions.
Over the years, there have been many special issues and supplements. Here are a selection of the highlights: -Ten separate reviews of the US Office of Technology Assessment Report on Alternatives to Animal Use in Research, Testing and Education (volume 14, 289-374, 1987).
-A FRAME 21st Anniversary Volume (volume 18, 1990 ).
-A FRAME 25th Anniversary Volume, dedicated to Dorothy Hegarty (volume 23, 1995) . The future of ATLA Recognition by the ARDF was a welcome indication that the aims of those who founded FRAME in 1969 are being achieved, but two serious problems now confront us. Firstly, like those who set up ATLA Abstracts, we have not succeeded in establishing a number of subscribers large enough to cover the costs of producing the journal. That does not surprise me, since I have long been aware that individuals and institutions, faced with an ever increasing number of journals with ever increasing costs, must make difficult choices. Where the journal concerned is as unusual as ATLA, the decision is a relatively easy one.
Secondly, FRAME's financial base has weakened very severely, so the Charity can no longer subsidise ATLA on the scale which has been possible over the past 38 years.
ATLA is a valuable resource in the alternatives field, providing a conduit for information both to and from scientists in many countries around the world. This role is particularly valuable in countries where awareness of the Three Rs concepts is still in its early stages. In view of this, the FRAME Trustees are currently doing all they can to ensure that the journal survives, by looking at ways to increase awareness of the journal and hopefully lead to an increase in subscriptions. In addition, the Trustees are constantly looking at ways to reduce the already-efficient production costs, through the timely use of new technologies as they become available. Another way forward, which is being investigated for the long term, is transferring the production of the journal to a commercial scientific publishers, although this would inevit ably lead to a significant alteration in ATLA's style. Co-ownership and sponsorship by organisations committed to the Three Rs is the preferred long-term option, as this is seen as being crucial in overcoming the otherwise unavoidable ethical and scientific dilemmas inherent in animal experimentation.
In one way or another, ATLA will continue to evolve over the forthcoming years. We can be safe in the knowledge that this further evolution will be based on a good reputation built up over decades, through the commitment and determination of all those who have contributed in many different ways. 
Michael Balls

